Cargando…
Artificial intelligence in mobile health for skin cancer diagnostics at home (AIM HIGH): a pilot feasibility study
BACKGROUND: Artificial intelligence (AI)-based mobile phone apps (mHealth) have the potential to streamline care for suspicious skin lesions in primary care. This study aims to investigate the conditions and feasibility of a study that incorporates an AI-based app in primary care and evaluates its p...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227364/ https://www.ncbi.nlm.nih.gov/pubmed/37261324 http://dx.doi.org/10.1016/j.eclinm.2023.102019 |
_version_ | 1785050754859401216 |
---|---|
author | Smak Gregoor, Anna M. Sangers, Tobias E. Eekhof, Just AH. Howe, Sydney Revelman, Jeroen Litjens, Romy JM. Sarac, Mohammed Bindels, Patrick JE. Bonten, Tobias Wehrens, Rik Wakkee, Marlies |
author_facet | Smak Gregoor, Anna M. Sangers, Tobias E. Eekhof, Just AH. Howe, Sydney Revelman, Jeroen Litjens, Romy JM. Sarac, Mohammed Bindels, Patrick JE. Bonten, Tobias Wehrens, Rik Wakkee, Marlies |
author_sort | Smak Gregoor, Anna M. |
collection | PubMed |
description | BACKGROUND: Artificial intelligence (AI)-based mobile phone apps (mHealth) have the potential to streamline care for suspicious skin lesions in primary care. This study aims to investigate the conditions and feasibility of a study that incorporates an AI-based app in primary care and evaluates its potential impact. METHODS: We conducted a pilot feasibility study from November 22nd, 2021 to June 9th, 2022 with a mixed-methods design on implementation of an AI-based mHealth app for skin cancer detection in three primary care practices in the Netherlands (Rotterdam, Leiden and Katwijk). The primary outcome was the inclusion and successful participation rate of patients and general practitioners (GPs). Secondary outcomes were the reasons, facilitators and barriers for successful participation and the potential impact in both pathways for future sample size calculations. Patients were offered use of an AI-based mHealth app before consulting their GP. GPs assessed the patients blinded and then unblinded to the app. Qualitative data included observations and audio-diaries from patients and GPs and focus-groups and interviews with GPs and GP assistants. FINDINGS: Fifty patients were included with a median age of 52 years (IQR 33.5–60.3), 64% were female, and 90% had a light skin type. The average patient inclusion rate was 4–6 per GP practice per month and 84% (n = 42) successfully participated. Similarly, in 90% (n = 45 patients) the GPs also successfully completed the study. GPs never changed their working diagnosis, but did change their treatment plan (n = 5) based on the app's assessments. Notably, 54% of patients with a benign skin lesion and low risk rating, indicated that they would be reassured and cancel their GP visit with these results (p < 0.001). INTERPRETATION: Our findings suggest that studying implementation of an AI-based mHealth app for detection of skin cancer in the hands of patients or as a diagnostic tool used by GPs in primary care appears feasible. Preliminary results indicate potential to further investigate both intended use settings. FUNDING: SkinVision B.V. |
format | Online Article Text |
id | pubmed-10227364 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-102273642023-05-31 Artificial intelligence in mobile health for skin cancer diagnostics at home (AIM HIGH): a pilot feasibility study Smak Gregoor, Anna M. Sangers, Tobias E. Eekhof, Just AH. Howe, Sydney Revelman, Jeroen Litjens, Romy JM. Sarac, Mohammed Bindels, Patrick JE. Bonten, Tobias Wehrens, Rik Wakkee, Marlies eClinicalMedicine Articles BACKGROUND: Artificial intelligence (AI)-based mobile phone apps (mHealth) have the potential to streamline care for suspicious skin lesions in primary care. This study aims to investigate the conditions and feasibility of a study that incorporates an AI-based app in primary care and evaluates its potential impact. METHODS: We conducted a pilot feasibility study from November 22nd, 2021 to June 9th, 2022 with a mixed-methods design on implementation of an AI-based mHealth app for skin cancer detection in three primary care practices in the Netherlands (Rotterdam, Leiden and Katwijk). The primary outcome was the inclusion and successful participation rate of patients and general practitioners (GPs). Secondary outcomes were the reasons, facilitators and barriers for successful participation and the potential impact in both pathways for future sample size calculations. Patients were offered use of an AI-based mHealth app before consulting their GP. GPs assessed the patients blinded and then unblinded to the app. Qualitative data included observations and audio-diaries from patients and GPs and focus-groups and interviews with GPs and GP assistants. FINDINGS: Fifty patients were included with a median age of 52 years (IQR 33.5–60.3), 64% were female, and 90% had a light skin type. The average patient inclusion rate was 4–6 per GP practice per month and 84% (n = 42) successfully participated. Similarly, in 90% (n = 45 patients) the GPs also successfully completed the study. GPs never changed their working diagnosis, but did change their treatment plan (n = 5) based on the app's assessments. Notably, 54% of patients with a benign skin lesion and low risk rating, indicated that they would be reassured and cancel their GP visit with these results (p < 0.001). INTERPRETATION: Our findings suggest that studying implementation of an AI-based mHealth app for detection of skin cancer in the hands of patients or as a diagnostic tool used by GPs in primary care appears feasible. Preliminary results indicate potential to further investigate both intended use settings. FUNDING: SkinVision B.V. Elsevier 2023-05-25 /pmc/articles/PMC10227364/ /pubmed/37261324 http://dx.doi.org/10.1016/j.eclinm.2023.102019 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Articles Smak Gregoor, Anna M. Sangers, Tobias E. Eekhof, Just AH. Howe, Sydney Revelman, Jeroen Litjens, Romy JM. Sarac, Mohammed Bindels, Patrick JE. Bonten, Tobias Wehrens, Rik Wakkee, Marlies Artificial intelligence in mobile health for skin cancer diagnostics at home (AIM HIGH): a pilot feasibility study |
title | Artificial intelligence in mobile health for skin cancer diagnostics at home (AIM HIGH): a pilot feasibility study |
title_full | Artificial intelligence in mobile health for skin cancer diagnostics at home (AIM HIGH): a pilot feasibility study |
title_fullStr | Artificial intelligence in mobile health for skin cancer diagnostics at home (AIM HIGH): a pilot feasibility study |
title_full_unstemmed | Artificial intelligence in mobile health for skin cancer diagnostics at home (AIM HIGH): a pilot feasibility study |
title_short | Artificial intelligence in mobile health for skin cancer diagnostics at home (AIM HIGH): a pilot feasibility study |
title_sort | artificial intelligence in mobile health for skin cancer diagnostics at home (aim high): a pilot feasibility study |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227364/ https://www.ncbi.nlm.nih.gov/pubmed/37261324 http://dx.doi.org/10.1016/j.eclinm.2023.102019 |
work_keys_str_mv | AT smakgregoorannam artificialintelligenceinmobilehealthforskincancerdiagnosticsathomeaimhighapilotfeasibilitystudy AT sangerstobiase artificialintelligenceinmobilehealthforskincancerdiagnosticsathomeaimhighapilotfeasibilitystudy AT eekhofjustah artificialintelligenceinmobilehealthforskincancerdiagnosticsathomeaimhighapilotfeasibilitystudy AT howesydney artificialintelligenceinmobilehealthforskincancerdiagnosticsathomeaimhighapilotfeasibilitystudy AT revelmanjeroen artificialintelligenceinmobilehealthforskincancerdiagnosticsathomeaimhighapilotfeasibilitystudy AT litjensromyjm artificialintelligenceinmobilehealthforskincancerdiagnosticsathomeaimhighapilotfeasibilitystudy AT saracmohammed artificialintelligenceinmobilehealthforskincancerdiagnosticsathomeaimhighapilotfeasibilitystudy AT bindelspatrickje artificialintelligenceinmobilehealthforskincancerdiagnosticsathomeaimhighapilotfeasibilitystudy AT bontentobias artificialintelligenceinmobilehealthforskincancerdiagnosticsathomeaimhighapilotfeasibilitystudy AT wehrensrik artificialintelligenceinmobilehealthforskincancerdiagnosticsathomeaimhighapilotfeasibilitystudy AT wakkeemarlies artificialintelligenceinmobilehealthforskincancerdiagnosticsathomeaimhighapilotfeasibilitystudy |